CLIA Kit for Teratocarcinoma Derived Growth Factor 1 (TDGF1)

CR; CRGF; CRIPTO; Cripto-1; Epidermal growth factor-like cripto protein CR1; Cripto-1 growth factor

  • CLIA Kit for Teratocarcinoma Derived Growth Factor 1 (TDGF1) Packages (Simulation)
  • CLIA Kit for Teratocarcinoma Derived Growth Factor 1 (TDGF1) Packages (Simulation)
  • CLIA Kit for Teratocarcinoma Derived Growth Factor 1 (TDGF1) Results demonstration
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Specificity of the CLIA Kit for Teratocarcinoma Derived Growth Factor 1 (TDGF1)

This assay has high sensitivity and excellent specificity for detection of Teratocarcinoma Derived Growth Factor 1 (TDGF1).
No significant cross-reactivity or interference between Teratocarcinoma Derived Growth Factor 1 (TDGF1) and analogues was observed.

Precision of the CLIA Kit for Teratocarcinoma Derived Growth Factor 1 (TDGF1)

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Teratocarcinoma Derived Growth Factor 1 (TDGF1) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Teratocarcinoma Derived Growth Factor 1 (TDGF1) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Stability of the CLIA Kit for Teratocarcinoma Derived Growth Factor 1 (TDGF1)

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Assay procedure summary of the CLIA Kit for Teratocarcinoma Derived Growth Factor 1 (TDGF1)

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 100µL Substrate Solution. Incubate 10 minutes at 37°C;
8. Read RLU value immediately.

Test principle of the CLIA Kit for Teratocarcinoma Derived Growth Factor 1 (TDGF1)

The microplate provided in this kit has been pre-coated with an antibody specific to Teratocarcinoma Derived Growth Factor 1 (TDGF1). Standards or samples are then added to the appropriate microplate wells with a biotin-conjugated antibody specific to Teratocarcinoma Derived Growth Factor 1 (TDGF1). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. Then the mixture of substrate A and B is added to generate glow light emission kinetics. Upon plate development, the intensity of the emitted light is proportional to the Teratocarcinoma Derived Growth Factor 1 (TDGF1) level in the sample or standard.;

Related products

Catalog No. Organism species: Homo sapiens (Human) Applications (RESEARCH USE ONLY!)
RPF997Hu01 Recombinant Teratocarcinoma Derived Growth Factor 1 (TDGF1) Positive Control; Immunogen; SDS-PAGE; WB.
PAF997Hu01 Polyclonal Antibody to Teratocarcinoma Derived Growth Factor 1 (TDGF1) WB; IHC; ICC; IP.
MAF997Hu21 Monoclonal Antibody to Teratocarcinoma Derived Growth Factor 1 (TDGF1) WB; IHC; ICC; IP.
SEF997Hu ELISA Kit for Teratocarcinoma Derived Growth Factor 1 (TDGF1) Enzyme-linked immunosorbent assay for Antigen Detection.
SCF997Hu CLIA Kit for Teratocarcinoma Derived Growth Factor 1 (TDGF1) Chemiluminescent immunoassay for Antigen Detection.
LMF997Hu Multiplex Assay Kit for Teratocarcinoma Derived Growth Factor 1 (TDGF1) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
GUESTBOOK